Prime Medicine Announces Breakthrough Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
On May 19, 2025, Prime Medicine announced positive initial data from the first patient dosed in its ongoing…